TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06713499

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1819 injection
Description: SHR-1819 injection.
Study: NCT06713252

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art therapy
Description: Through music, painting, dance and other forms, art therapy can not only help patients regulate their emotions, relieve anxiety and depression, but also activate different areas of the brain to promote neuroplasticity, thereby promoting the recovery of motor function

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Regular therapy
Description: Standard treatment
Study: NCT06713837

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: High intensity therapies
Description: * High and intermediate dose Cytarabine~* Mitoxantrone - Etoposide - Cytarabine (MEC)~* fludarabine - cytarabine - idarubicin - G-CSF (FLAG-IDA)~* cladribine - high dose cytarabine (2CDA+HDAraC)~* mitoxantrone - intermediate dose cytarabine (MiDAC)~* fludarabine - amsacrine - cytarabine (FLAMSA)~* Mitoxantrone - Intermediate-dose Cytarabine (HAM)~* 3+7 (cytarabine and daunorubicine or idarubicine)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low intensity therapies
Description: * Venetoclax+hypomethylating agent (decitabine, azacitidine)~* Venetoclax+low dose cytarabine~* Gilteritinib alone or in combination with low dose hypomethylating agent or low dose cytarabine~* 2CDA 5mg/sqm + low dose cytarabine~* Glasdegib+low dose cytarabine~* Ivosidenib alone or in combination with low dose hypomethylating agent or low dose cytarabine~* Single agent Gemtuzumab or Gemtuzumab in combination with alone or in combination with low dose hypomethylating agent or low dose cytarabine
Study: NCT06713408

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental (Music)
Description: Audio recordings consisting of pentatonic music and neva makam will be uploaded to the patients' phones by the researcher. Patients will be advised to listen to these music during the period they receive chemotherapy, and they will also be asked to listen to these music in at least 15-20 minute sessions per day and for at least 3 days during the week following chemotherapy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental (Affirmation)
Description: Patients in this group will be asked to listen to the audio recording with pentatonic music and neva makam in the background, along with the affirmation sentences provided in the appendix. Patients will be advised to listen to these music during the period they receive chemotherapy, and they will also be asked to listen to these music in at least 15-20 minute sessions per day and for at least 3 days during the week following chemotherapy.
Study: NCT04933708

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Labor Podcast
Description: Listening to podcasts.~Topics include:~Labor Anesthesia, Induction of Labor, Second Stage of Labor, Reasons for Cesarean Section, Postpartum Recovery, Complications of Labor and Birth
Study: NCT06713187

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: interleukin 23
Description: assessment of interleukin 23 in Sera of patients using ELIZA

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: interleukin 23
Description: assessment of interleukin 23 in Sera of patients using ELIZA

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: interleukin 23
Description: assessment of interleukin 23 in Sera of patients using ELIZA
Study: NCT06640036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapeseed oil
Description: During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapeseed oil
Description: During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.
Study: NCT06713551

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Big Amplitude Calisthenic Group Exercise with Music
Description: The exercise program will consist of balance and mobility-oriented exercises such as reaching forward and upward while sitting on a chair, taking steps forward, backward, sideways and backward while standing, transferring weight, counting in place, sit-to-stand exercises, walking, changing directions or walking over obstacles (Appendix: Exercise Program). This exercise program will be applied to the first group with the accompaniment of classical Western music, while the other group will be applied without music. The exercise programs will be performed for both groups for 40 minutes, two days a week and for eight weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Big Amplitude Calisthenic Group Exercise
Description: The exercise program will consist of balance and mobility-oriented exercises such as reaching forward and upward while sitting on a chair, taking steps forward, backward, sideways and backward while standing, transferring weight, counting in place, sit-to-stand exercises, walking, changing directions or walking over obstacles (Appendix: Exercise Program). This exercise program will be applied to the first group with the accompaniment of classical Western music, while the other group will be applied without music. The exercise programs will be performed for both groups for 40 minutes, two days a week and for eight weeks.
Study: NCT06711744

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Implant stability quotient
Description: Screw a smart peg into the implant and record the values from a dedicated device
Study: NCT06640036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapeseed oil
Description: During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapeseed oil
Description: During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapeseed oil
Description: During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapeseed oil
Description: During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Butter
Description: During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Butter
Description: During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Butter
Description: During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Butter
Description: During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.
Study: NCT06711744

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Implant stability quotient
Description: Screw a smart peg into the implant and record the values from a dedicated device
Study: NCT06711393

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Traditional home exercise including balance and muscle strength training 15 minutes at the time and three times over the week. In addition, game-based exercises 15 minutes at the time and three times over the week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise as usual
Description: Traditional home exercise including balance and muscle strength training 15 minutes at the time and three times over the week without exergaming.
Study: NCT06706882

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Training: VIRTRAEL/LUCCIDY
Description: Cognitive stimulation of the different cognitive functions to be addressed will be conducted in the following sessions:~* Session 1: Shopping lists. Balls. Gift shopping. Long-term memory of the Shopping List.~* Session 2: Disordered objects. Whats different? Semantic series. Logical series. Puzzle pieces. Semantic analogies.~* Session 3: Classifiable objects. Gift shopping. Bag of objects.~* Session 4: Shopping lists. Balls. Disordered objects. Long-term memory of the Shopping List.~* Session 5: Semantic series. Logical series. Puzzle pieces. Semantic analogies. Gift shopping.~* Session 6: Classifiable objects. Bag of objects. Disordered objects.~* Session 7: Shopping lists. Semantic series. Logical series. Puzzle pieces. What\&amp;#39;s different? Semantic analogies. Long-term memory of the Shopping List.~* Session 8: Disordered objects. Gift shopping. Balls.~* Session 9: Bag of objects. Semantic series. Logical series. Whats different? Semantic analogies. Classifiable objects.
Study: NCT06640036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Butter
Description: During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Butter
Description: During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.
Study: NCT06706882

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Standard Training: Reflection Group (TAU) (Andalusian Institute of Women, 2010)
Description: This 9-session program explores how societal norms shape women\&amp;#39;s roles and identities. In Session 1, it discusses how women are socially positioned as caretakers in relationships and introduces the concept of the self in relation. Session 2 delves into gender conflicts, focusing on the tension between societal demands and personal desires. Session 3 explores guilt when women fail to meet expected roles, and the fear of being selfish when prioritizing their own needs. Session 4 examines how dependence is fostered by seeking external validation for self-worth. Session 5 critiques romantic love as a cultural tool to prioritize men desires over women. Session 6 analyzes how intimate partner violence (IPV) emerges as a means to maintain power imbalances in relationships. Session 7 looks at the family role in socializing women, while Session 8 explores fears of abandonment. Finally, Session 9 focuses on building life skills and concludes the program.
Study: NCT06707324

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: drug injected between the rectus abdominis muscle and the transversus abdominis muscle
Description: 20 ml of 0.25% bupivacaine + 8 mg dexamethasone between the rectus abdominis muscle and the transversus abdominis muscle on both sides

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: drug injected in the external oblique intercostal plane on both sides
Description: 20 ml of 0.25% bupivacaine+ 8 mg dexamethasone into the external oblique intercostal plane on both sides
Study: NCT04924699

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRG002
Description: Administrated intravenously
Study: NCT06711835

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-body vibration and Jumping
Description: The subjects were first asked to jump in place 20 times, as if they were jumping rope. Then, whole-body vibration was applied. While the participants stood upright on the whole-body vibration device, low-amplitude (1.2 mm) vibrations were applied at eight different frequencies (25, 27, 29, 31, 33, 35, 37, 39 Hz), each lasting for 10 seconds, with a 5-second rest period in between.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-body vibration and Jumping
Description: The subjects were first asked to jump in place 20 times, as if they were jumping rope. Then, whole-body vibration was applied. While the participants stood upright on the whole-body vibration device, low-amplitude (1.2 mm) vibrations were applied at eight different frequencies (25, 27, 29, 31, 33, 35, 37, 39 Hz), each lasting for 10 seconds, with a 5-second rest period in between.
Study: NCT05144217

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 capsule per day of placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2x 140 mg per day
Description: 2 capsule per day of silimarit

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3x 280 mg per day
Description: 3 capsule per day of silimarit

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1x 1120 mg
Description: 8 capsule per day of silimarit
Study: NCT04924699

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab Emtansine for Injection
Description: Administrated intravenously
Study: NCT05966207

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual Cognitive Stimulation
Description: The Individual Cognitive Stimulation will be conducted by caregivers, with support by the research team. The intervention will span 12 weeks, consisting of three weekly sessions (30 minutes each session), totaling 36 sessions. Caregivers in this study will utilize a previously translated and validated version of Making a Difference 3 - Individual Intervention of Cognitive Stimulation - A manual for caregivers, specifically adapted for the European Portuguese population.
Study: NCT04718649

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celebrex with Joins or not
Description: The enrolled patienst will be divided into the group taking celecoxib 200mg with Joins tab together and the group taking celecoxib 200mg with Joins placebo in the same probability of 2:1 according to the randomization table at the first outpatient visit. Among the co-researchers, one researcher who is in charge of patient assignment will create a randomization table through computer generated randomization. And this researcher who is charge of the patient assignment will not intervene in any other process of this study, and only participates in the task of selecting the assigned group using random checks. The evaluation will be evaluated by an researcher who is not aware of the patient allocation according to the randomization table among researchers participating in the clinical study

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Celebrex with Joins or not
Description: The enrolled patienst will be divided into the group taking celecoxib 200mg with Joins tab together and the group taking celecoxib 200mg with Joins placebo in the same probability of 2:1 according to the randomization table at the first outpatient visit. Among the co-researchers, one researcher who is in charge of patient assignment will create a randomization table through computer generated randomization. And this researcher who is charge of the patient assignment will not intervene in any other process of this study, and only participates in the task of selecting the assigned group using random checks. The evaluation will be evaluated by an researcher who is not aware of the patient allocation according to the randomization table among researchers participating in the clinical study
Study: NCT04802551

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory integration therapy
Description: Sensory integration disorder is defined as the inability of a person to use the information he / she receives through his / her senses properly in order to continue his daily life properly. Intervention group have some therapy sessions which include sensory integration therapy exercises.
Study: NCT05877638

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel
Description: (FDA) 510(k) cleared wound care medical devices formulated with a novel biocompatible chitosan derivative, poly (acetyl, arginyl) glucosamine. SynePure is optimized for the cleansing and debridement of wounds and thermal injuries, and Catasyn serves as a protective gel dressing.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SILVADENE Cream 1% (silver sulfadiazine)
Description: SILVADENE Cream 1% (silver sulfadiazine) is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.
Study: NCT04707794

Intervention type: DRUG
Intervention: Sevoflurane
Description: Sevoflurane delivery will will be titrated to maintain anaesthesia depth of 50 (BIS score) using bispectral (BIS) index monitioring

Intervention type: DRUG
Intervention: Desflurane
Description: Desflurane delivery will be titrated to maintain anaesthesia depth of 50 (BIS score) using bispectral (BIS) index monitioring
Study: NCT06120751

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TTVA
Description: Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: TT
Description: Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0
Study: NCT06640036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.
Study: NCT04650893

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Ketorolac
Description: To assess the efficacy of the meds for dysphagia and dysphonia following ACDF

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Dexamethasone
Description: To assess the efficacy of the meds for dysphagia and dysphonia following ACDF

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control
Study: NCT05510934

Intervention type: BEHAVIORAL
Intervention: Shared-care model
Description: A Shared care follow-up strategy involving patients, PCPs and specialists that uses an automated reminder system (TCARS).
Study: NCT06429657

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine with propofol
Description: Propofol at a rate of 300 mcg/kg/hr (5 mcg/kg/min) with the addition of ketamine at a rate of 1000-5000 mcg/kg/hr (16.67 - 83.33 mcg/kg/min) (using weight at time of admission) with an additional 2 mg/kg (2000 mcg/kg) bolus of ketamine

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam
Description: Standard of Care analgosedation of choice using propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam administered according to the institutional SOC guidelines.
Study: NCT04933422

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM93
Description: oral capsule of CM93 administered once daily
Study: NCT05027789

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Guided
Description: People in this arm will come to 15 information sessions. These sessions will provide training and education on memory support strategies and healthy lifestyles. You will decide how you want to implement this information into your daily life.
Study: NCT04230694

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dexcom Generation 6 CGM (Dexcom Gen6) device
Description: Standing orders for blood sugars less than 100 will allow for administration of glucose replacement in the intervention group based on Dexcom Gen6 readings.
Study: NCT05027789

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured Group
Description: People in this group will come to 15 information sessions. The study will provide recommended behavior targets (like how much exercise you should have each week). Participants in this group will either receive an iPad or have a special application installed on their own personal device. They will receive training on how to use the application, and will be asked to use the application to record their activities and receive reminders.
Study: NCT04230694

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dexcom Generation 6 CGM (Dexcom Gen6) device
Description: Standing orders for blood sugars less than 100 will allow for administration of glucose replacement in the intervention group based on Dexcom Gen6 readings.
Study: NCT05440188

Intervention type: DIAGNOSTIC_TEST
Intervention: Breath Detect Platform
Description: Use of the Breath Detect platform for respiratory health monitoring.
Study: NCT05777343

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise and PNE
Description: Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive training
Description: Online sessions of cognitive training.
Study: NCT06327659

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 30 mL syringe manual thrombectomy catheter
Description: 30 mL syringe manual thrombectomy catheter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 50 mL syringe manual thrombectomy catheter
Description: 50 mL syringe manual thrombectomy catheter
Study: NCT04964843

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Description: N-acetylcysteine is an FDA approved medication that is used to treat acetaminophen overdose.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05030246

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib/Toripalimab
Description: Surufatinib 250mg will be taken orally once daily continuously through a 21-day cycle of study treatment. Toripalimab 240mg will be intravenously administered on Day 1 of each cycle.
Study: NCT05988489

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dynamic Deconstructive Psychotherapy (DDP)
Description: DDP treatment with an assigned therapist for up to 12 months

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Intervention and Contact (BIC)
Description: BIC treatment with an assigned therapist for up to 12 months